Mammalian cGMP Manufacture

Protein contract manufacturing excellence since 1995
Cobra provides GMP manufacture of mammalian derived therapeutics proteins (monoclonal antibodies) and biosimilars, following Good Manufacturing Practices of production and testing to ensure quality products for customers’ preclinical and clinical trials through to commercial supply.
Processes are clearly defined, controlled and validated to ensure compliance, clear records are made, and any deviations are investigated and documented. We are able to provide a certificate of 
cGMP compliance and GMP campaign summary report with QA review of completed documentation.
In 1995 we manufactured our first protein, a monoclonal antibody (mAb) to target stem cells, and since then we have manufactured a diverse range of proteins and biosimilars, including vaccines for malaria and meningitis, and disease-modifying protein therapies for arthritis, conjunctivitis and hepatitis B and C.

Other Mammalian Protein Services...

In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site. It is recommended that you allow all cookies. Allow all cookies